Clinical trial
ACT MALI: Treatment of Malaria Based on Combination Therapies
NCT00452907 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00452907 |
|---|---|
| Title | ACT MALI: Treatment of Malaria Based on Combination Therapies |
| Official title | Assessment of the Public Health Benefit of Artemisinine Based Combination Therapies for Uncomplicated Malaria Treatment in Mali |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Artesunate, Artesunate + Sulfadoxine-Pyrimethamine, arthemether + lumefantrine |
| Enrollment | 780 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 28, 2007 |
| Last update posted | Feb 17, 2010 |
| Countries | Mali |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: